Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when KORU Medical Systems, Inc. publishes a filing, an earnings call transcript or a press release.

Get KRMD alerts

About Adam Kalbermatten

Adam Kalbermatten is recorded as Board Member at KORU Medical Systems, Inc. (KRMD) since January 1, 2027 and CEO at KORU Medical Systems, Inc. (KRMD) since July 1, 2026. KORU Medical Systems, Inc. reported in an 8-K filed March 16, 2026 that Adam Kalbermatten was appointed Chief Executive Officer, effective July 1, 2026. KORU Medical Systems, Inc. reported in an 8-K filed March 16, 2026 that Adam Kalbermatten was appointed Board, effective January 1, 2027. KORU Medical Systems, Inc. reported in an 8-K filed March 16, 2026 that Adam Kalbermatten was appointed President, effective March 15, 2026. Adam Kalbermatten has spoken on 2 earnings calls across 1 company, most recently for KORU Medical Systems, Inc. on August 5, 2026. KORU Medical Systems, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at KORU Medical Systems, Inc. includes James Beck (CEO), James M. Beck (CEO and Board Member), Mr. Kalbermatten (CEO) and 7 others.

“Mr. Kalbermatten has been appointed to replace Ms. Tharby as the Company's President effective March 15, 2026 and will succeed Ms. Tharby as Chief Executive Officer effective July 1, 2026.”
KORU Medical Systems, Inc. Form 8-K, filed March 16, 2026 · Read the filing
“The Company will cause the Board to appoint Mr. Kalbermatten to the Board effective January 1, 2027, subject to the Company's organizational documents, applicable law and Nasdaq Capital Market rules.”
KORU Medical Systems, Inc. Form 8-K, filed March 16, 2026 · Read the filing

Adam Kalbermatten on recent calls

“I'll begin with commentary on this quarter's highlights and strategic progress. Tom will then speak to our financial performance and the current assumptions around guidance before we open the line for questions.”
CEO, Second Quarter 2026 Financial Results Conference Call ·
“I want to take a few minutes to talk about what lies ahead. On the domestic side, we now have two new non-IG drugs on label.”
Other, KORU Medical Systems, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at KORU Medical Systems, Inc.

Recent activity